Shares of telemedicine company Teladoc Health (NYSE: TDOC) surprisingly popped on Thursday after Citron Research gave it a glowing recommendation. As of 3:30 p.m. ET, Teladoc stock was up 7%, but ...

Teladoc witnessed a price rise after Citron Research highlighted strong growth prospects following the company’s Goldman Sachs presentation, where management revealed that embedding BetterHelp ...

Teladoc Health (NYSE: TDOC) is scheduled to announce Q2 results on Tuesday, July 29th, after market close, and investor focus will be on the details behind usual numbers—especially segment trends, ...

Teladoc research shows AI-powered 'nudges' can improve diabetes members' engagement, health outcomes By Heather Landi Jun 24, 2024 8:10am ...

The results come on the heels of previous research that demonstrated Teladoc Health’s ability to proactively identify a person at-risk for uncontrolled outcomes more than a year in advance using AI.

Live Updates Live Coverage Has Ended 'Under-the-Radar' AI Play 2:57 pm by Gerelyn Terzo Citron Research has come out touting Teladoc Health (Nasdaq: TDOC) as an “under-the-radar” AI stock ...

PURCHASE, NY, June 24, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (TDOC), the global leader in whole-person virtual care, released new data today from two studies, presented at the American Diabetes ...